[Microbial spectrum and microbial resistance in ambulatory and stationary urological patients].
D000667:Ampicillin / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects* / Q000302:isolation & purification; D001437:Bacteriuria / Q000382:microbiology; D002512:Cephalothin / Q000494:pharmacology; D002701:Chloramphenicol / Q000494:pharmacology; D003091:Colistin / Q000494:pharmacology; D013293:Enterococcus faecalis / Q000187:drug effects / Q000302:isolation & purification; D004926:Escherichia coli / Q000187:drug effects / Q000302:isolation & purification; D005839:Gentamicins / Q000494:pharmacology; D006801:Humans; D007612:Kanamycin / Q000494:pharmacology; D009268:Nalidixic Acid / Q000494:pharmacology*; D009582:Nitrofurantoin / Q000494:pharmacology; D010403:Penicillin Resistance; D011511:Proteus / Q000187:drug effects / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000302:isolation & purification; D011704:Pyelonephritis / Q000382:microbiology; D013210:Staphylococcus / Q000187:drug effects / Q000302:isolation & purification; D013291:Streptococcus / Q000187:drug effects / Q000302:isolation & purification; D013752:Tetracycline / Q000494:pharmacology; D014570:Urologic Diseases / Q000188:drug therapy / Q000382:microbiology*
D000900:Anti-Bacterial Agents; D005839:Gentamicins; D009268:Nalidixic Acid; D007612:Kanamycin; D002701:Chloramphenicol; D000667:Ampicillin; D009582:Nitrofurantoin; D013752:Tetracycline; D002512:Cephalothin; D003091:Colistin
Keimspectrum und Erregerresistenz bei ambulanten und stationären urologischen Patienten.